https://www.fool.com/earnings/call-transcripts/2020/02/06/alnylam-pharmaceuticals-inc-alny-q4-2019-earnings.aspx
Alnylam Pharmaceuticals Inc (ALNY) Q4 2019 Earnings Call Transcript | The Motley Fool
Feb 6, 2020 - ALNY earnings call for the period ending December 31, 2019.
alnylam pharmaceuticals incearnings call transcriptq4 2019
https://www.illumina.com/company/news-center/press-releases/2025/65116392-fb5c-4513-a1fe-b36f8f8a4ea5.html
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic...
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
alnylam pharmaceuticalsjoinsalliancegenomicdiscovery
https://www.biospace.com/press-releases/alnylam-pharmaceuticals-reports-first-quarter-2025-financial-results-and-highlights-recent-period-progress
Alnylam Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Period...
2025 financial resultsalnylam pharmaceuticalsfirst quarter
https://www.oanda.com/eu-ro/trading/shares/us/alnylam-pharmaceuticals
Alnylam Pharmaceuticals Inc (ALNY) Trading | Shares / Shares CFDs | OANDA
Trade Alnylam Pharmaceuticals Inc (ALNY) shares CFDs with OANDA. View live charts and current market interest for this stock.
alnylam pharmaceuticals inctradingsharescfdsoanda
https://www.prnewswire.com/il/news-releases/medison-pharma-and-alnylam-pharmaceuticals-announce-expansion-of-their-multi-regional-partnership-in-europe-and-israel-to-commercialize-rnai-therapeutics-in-additional-latam-and-apac-markets-including-australia-302131423.html
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership...
/PRNewswire/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies for patients in international...
alnylam pharmaceuticals
https://www.financialcontent.com/quote/NQ:ALNY/news
Breaking News about Alnylam Pharmaceuticals, Inc. - Common Stock (Nasdaq:ALNY) | FinancialContent
Latest news about Alnylam Pharmaceuticals, Inc. - Common Stock (Nasdaq:ALNY)
alnylam pharmaceuticals incbreaking newscommon stock
https://informaconnect.com/life-sciences-accounting-reporting-congress/speakers/gina-tracey/
Gina Tracey - Alnylam Pharmaceuticals | Life Sciences Accounting & Reporting Congress Speaker
alnylam pharmaceuticalslife sciencesginatraceyaccounting
https://www.benzinga.com/analyst-ratings/22/06/27586154/analyst-ratings-for-alnylam-pharmaceuticals
Analyst Ratings for Alnylam Pharmaceuticals - Alnylam Pharmaceuticals (NASDAQ:ALNY) - Benzinga
Jun 7, 2022 - Analysts have provided the following ratings for Alnylam Pharmaceuticals (NASDAQ:ALNY) within the last quarter:
analyst ratingsalnylam pharmaceuticalsnasdaqbenzinga
https://informaconnect.com/tides/speakers/joshua-brooks-phd/
Joshua Brooks, PhD - Alnylam Pharmaceuticals | TIDES USA: Oligonucleotide & Peptide Therapeutics...
joshua brooksalnylam pharmaceuticalsphdtidesusa
https://informaconnect.com/speaker-programs/speakers/shelley-l-hays-fisher-rn-bsn/
Shelley L. Hays-Fisher, RN, BSN - Alnylam Pharmaceuticals | Speaker Programs Summit Speaker
alnylam pharmaceuticalsspeaker programsshelleyhaysfisher
https://www.upguard.com/security-report/alnylam
Alnylam Pharmaceuticals Security Rating, Vendor Risk Report, and Data Breaches | UpGuard
Compare Alnylam Pharmaceuticals's security performance with other companies. Learn about data breaches, cyber attacks, and security incidents involving Alnylam...
alnylam pharmaceuticalssecurity ratingvendor riskdata breaches
https://www.fxempire.com/stocks/alny/news
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Forecasts & News | FXEmpire
Explore the latest news and expert analysis on Alnylam Pharmaceuticals, Inc. (ALNY) stock. Stay informed with in-depth forecasts, and insightful commentary on...
alnylam pharmaceuticals incstock forecastsnews
https://www.businesswire.com/news/home/20251030005751/en/Alnylam-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Highlights-Recent-Period-Progress
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ...
2025 financial resultsalnylam pharmaceuticalsthird quarter
https://www.financialcontent.com/quote/NQ:ALNY/competitors
Competitors for Alnylam Pharmaceuticals, Inc. - Common Stock (Nasdaq:ALNY) | FinancialContent
alnylam pharmaceuticals inccommon stockcompetitorsnasdaq
https://www.financialcontent.com/quote/NQ:ALNY/about
The History Of Alnylam Pharmaceuticals, Inc. - Common Stock (Nasdaq:ALNY) | FinancialContent
Alnylam Pharmaceuticals, Inc. (ticker: ALNY) has long been at the forefront of innovative research in the biotechnology sector. Known primarily for its...
the history ofalnylam pharmaceuticals inccommon stock
https://www.finder.com/stock-trading/buy-alnylam-pharmaceuticals-stock
How to Buy Alnylam Pharmaceuticals Stock (ALNY)
Aug 10, 2021 - We explain how to buy Alnylam Pharmaceuticals Inc stock, compare the best stock trading platforms and use a detailed analysis to learn about (ALNY).
how to buyalnylam pharmaceuticalsstock
https://companiesmarketcap.com/alnylam-pharmaceuticals/cost-to-borrow/
Alnylam Pharmaceuticals (ALNY) - Cost to borrow
List of the companies with highest cost to borrow on Interactive Brokers. The cost to borrow is in annualized percents.
alnylam pharmaceuticalscostborrow
https://www.businesswire.com/news/home/20260324362969/en/Viz.ai-Partners-with-Alnylam-Pharmaceuticals-to-Advance-Earlier-Identification-and-Care-Coordination-in-Cardiac-Amyloidosis
Viz.ai Partners with Alnylam Pharmaceuticals to Advance Earlier Identification and Care...
Viz.ai, the leader in AI-powered disease detection and care coordination, today announced a partnership with Alnylam Pharmaceuticals, the leading RNAi therap...
ai partnersalnylam pharmaceuticals
https://www.benzinga.com/news/21/12/24791655/51-biggest-movers-from-yesterday
51 Biggest Movers From Yesterday - Alnylam Pharmaceuticals (NASDAQ:ALNY) - Benzinga
Dec 28, 2021 - Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with...
from yesterdayalnylam pharmaceuticals51biggestmovers
https://www.fool.com/earnings/call-transcripts/2021/08/03/alnylam-pharmaceuticals-inc-alny-q2-2021-earnings/
Alnylam Pharmaceuticals, inc (ALNY) Q2 2021 Earnings Call Transcript | The Motley Fool
Aug 4, 2021 - ALNY earnings call for the period ending June 30, 2021.
alnylam pharmaceuticals incearnings call transcript
https://www.financialcontent.com/quote/NQ:ALNY/chart
Stock Chart for Alnylam Pharmaceuticals, Inc. - Common Stock (Nasdaq:ALNY) | FinancialContent
View a technical stock chart for Alnylam Pharmaceuticals, Inc. - Common Stock (Nasdaq:ALNY)
alnylam pharmaceuticals incstock chartcommonnasdaq
https://finviz.com/quote?t=ALNY&ty=oc&ta=0&p=d
ALNY - Alnylam Pharmaceuticals Inc Options
ALNY - Alnylam Pharmaceuticals Inc - Stock screener for investors and traders, financial visualizations.
alnylam pharmaceuticals incoptions
https://www.benzinga.com/quote/ALNY/news
Latest Alnylam Pharmaceuticals Stock News | NASDAQ:ALNY | Benzinga
Get the latest news on Alnylam Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on ALNY performance
alnylam pharmaceuticalsstock newslatestnasdaqbenzinga
https://www.fool.com/investing/general/2016/01/09/behind-alnylam-pharmaceuticals-december-plunge.aspx
Behind Alnylam Pharmaceuticals' December Plunge | The Motley Fool
Jan 9, 2016 - Shares performed poorly in a month filled with good news.
alnylam pharmaceuticalsthe motleybehinddecemberplunge
https://www.benzinga.com/news/earnings/23/02/31069825/alnylam-pharmaceuticalss-return-on-capital-employed-insights
Alnylam Pharmaceuticals's Return On Capital Employed Insights - Alnylam Pharmaceuticals...
return on capital employedalnylam pharmaceuticalsinsights
https://www.benzinga.com/25/03/44463008/jp-morgan-sees-convincing-multi-billion-dollar-opportunity-for-alnylam-pharmaceuticals-upgrades-stock
Alnylam Pharmaceuticals Presents 'Convincing Multi-Billion Dollar Opportunity': Analyst Upgrades...
Mar 24, 2025 - Alnylam's Amvuttra wins FDA approval for ATTR-CM, expanding its market reach. JP Morgan upgrades the stock, projecting strong sales and a multi-billion...
alnylam pharmaceuticalspresentsconvincingmultibillion
https://www.marketscreener.com/quote/stock/ALNYLAM-PHARMACEUTICALS-I-8322/
Alnylam Pharmaceuticals, Inc. Stock (ALNY) - Quote Nasdaq- MarketScreener
Alnylam Pharmaceuticals, Inc. (ALNY:NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Alnylam Pharmaceuticals, Inc. |...
alnylam pharmaceuticals incstockquotenasdaqmarketscreener
https://www.oanda.com/eu-lv/trading/shares/us/alnylam-pharmaceuticals
Alnylam Pharmaceuticals Inc (ALNY) Trading | Shares / Shares CFDs | OANDA
Trade Alnylam Pharmaceuticals Inc (ALNY) shares CFDs with OANDA. View live charts and current market interest for this stock.
alnylam pharmaceuticals inctradingsharescfdsoanda
https://www.alnylam.jp/
Alnylam® Pharmaceuticals | Alnylam Japan
pharmaceuticalsalnylamjapan
https://www.biospace.com/alnylam-pharmaceuticals-studying-the-history-of-genzyme-corporation-eyes-drug-to-make-big-difference-for-rare-disease
Alnylam Pharmaceuticals Studying the History of Genzyme Corporation Eyes Drug to Make Big...
the history of
https://www.benzinga.com/general/biotech/21/07/22246992/peptidream-inks-2-2b-deal-to-broaden-alnylams-sirna-delivery-scope
PeptiDream Inks $2.2B Deal To Broaden Alnylam's siRNA Delivery Scope - Alnylam Pharmaceuticals...
https://www.marketscreener.com/news/transcript-alnylam-pharmaceuticals-inc-presents-at-citi-s-biopharma-back-to-school-conference-s-ce7d59dbda81f724
Transcript : Alnylam Pharmaceuticals, Inc. Presents at Citi's Biopharma Back to School Conference,...
Sep 3, 2025 - Presenter SpeechDavid Lebowitz Thank you all. Welcome all again to the 2025 Citi Biopharma Conference in Boston. Next on the docket, we have Alnylam. If you...
alnylam pharmaceuticals inc
https://www.biospace.com/alnylam-pharmaceuticals-initiates-phase-i-clinical-study-of-aln-rsv01-an-rnai-therapeutic-for-the-treatment-of-respiratory-syncytial-virus-rsv-infe
Alnylam Pharmaceuticals Initiates Phase I Clinical Study Of ALN-RSV01, An RNAi Therapeutic For The...
https://www.naturalnews.com/2022-07-20-alnylam-pfizer-moderna-patent-infringement-covid-vaccines.html
Alnylam Pharmaceuticals claims Pfizer, Moderna infringed on its patent rights to make COVID-19...
Alnylam Pharmaceuticals has escalated its patent fight against Pfizer and Moderna, claiming that the Wuhan coronavirus (COVID-19) vaccines of the two companies...
https://www.benzinga.com/markets/options/23/10/35200165/10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In Today's Session - Alnylam Pharmaceuticals (NASDAQ:ALNY),...
https://www.biospace.com/alnylam-pharmaceuticals-to-webcast-conference-call-discussing-fourth-quarter-and-full-year-2014-financial-results
Alnylam Pharmaceuticals To Webcast Conference Call Discussing Fourth Quarter And Full Year 2014...
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/market-sentiment-around-loss-making-alnylam-pharmaceuticals-1
Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - Simply Wall St...
We feel now is a pretty good time to analyse Alnylam Pharmaceuticals, Inc.'s ( NASDAQ:ALNY ) business as it appears the...
alnylam pharmaceuticals inc
https://www.marketscreener.com/news/alnylam-pharmaceuticals-inc-announces-new-data-from-helios-b-phase-3-study-demonstrate-lower-rates-ce7d5bdadf8ff223
Alnylam Pharmaceuticals, Inc. Announces New Data from HELIOS-B Phase 3 Study Demonstrate Lower...
Sep 28, 2025 - Alnylam Pharmaceuticals, Inc. announced results from new analyses of the HELIOS-B Phase 3 study of AMVUTTRA , an RNAi therapeutic approved for the treatment of...
alnylam pharmaceuticals inc